cancer
one
lead
health
concern
human
anim
health
sinc
tumorigenesi
process
complet
understood
known
virus
induc
carcinogenesi
highli
import
identifi
novel
oncovirus
extens
studi
underli
oncogen
mechan
investig
case
diffus
histiocyt
sarcoma
year
old
slow
lori
nycticebu
coucang
use
broad
spectrum
viru
discoveri
techniqu
novel
parvoviru
discov
phylogenet
analysi
perform
fulli
sequenc
genom
demonstr
repres
first
member
novel
genu
possibl
caus
correl
viru
malign
investig
serum
organ
sampl
anim
n
coucang
n
pygmaeu
screen
novel
viru
sampl
collect
origin
infect
anim
posit
viru
present
test
organ
intestin
liver
spleen
kidney
lung
bank
serum
sampl
collect
year
death
attempt
identifi
latent
viral
form
integr
episom
unsuccess
increas
variat
viral
sequenc
year
consist
absenc
latenc
sinc
well
known
parvovirus
depend
cell
divis
success
replic
hypothes
viru
could
benefit
constantli
divid
cancer
cell
may
caus
histiocyt
sarcoma
also
possibl
conjectur
viru
role
delay
tumor
progress
report
might
bring
new
excit
opportun
recogn
virus
use
cancer
virotherapi
persist
viremia
novel
parvoviru
slow
lori
nycticebu
coucang
diffus
histiocyt
sarcoma
front
microbiol
sunda
slow
lori
nycticebu
coucang
strepsirrhin
primat
belong
famili
lorisida
nocturn
arbor
prosimian
speci
nativ
indonesia
sumatra
western
malaysia
peninsular
malaysia
singapor
southern
thailand
nekari
streicher
slow
lori
list
vulner
speci
intern
union
conserv
natur
iucn
iucn
red
list
threaten
speci
avail
www
iucnredlistorg
protect
law
malaysia
thailand
indonesia
sinc
conserv
statu
matter
concern
biggest
threat
endang
anim
pet
tradethey
commonli
protect
primat
speci
sold
exot
pet
southeast
asia
nekari
nijman
habitat
loss
fact
kill
crop
pest
also
jeopard
surviv
nekari
streicher
reason
better
understand
caus
dynam
diseas
n
coucang
advantag
conserv
attempt
captiv
manag
speci
remick
et
al
addit
valuabl
inform
gather
studi
diseas
nonhuman
primat
turn
might
benefici
human
health
investig
case
histiocyt
sarcoma
hs
n
coucang
identifi
duke
lemur
center
dlc
durham
north
carolina
hs
highli
aggress
hematopoiet
tumor
defin
malign
prolifer
cell
show
morpholog
immunophenotyp
featur
matur
tissu
histiocyt
cell
innat
immun
system
deriv
bone
marrow
monocyt
differenti
dendrit
cell
tissu
local
macrophag
fulmer
mauldin
takahashi
nakamura
tumor
local
dissemin
lymph
node
common
site
prolifer
follow
organ
gastrointestin
tract
spleen
soft
tissu
skin
takahashi
nakamura
rare
type
cancer
human
case
report
speci
anim
includ
chicken
dog
cat
camel
macaqu
lemur
fulmer
mauldin
friedrich
young
soshin
et
al
molenaar
et
al
remick
et
al
takahashi
nakamura
although
caus
hs
larg
unknown
viral
etiolog
postul
exist
virus
involv
develop
hematopoiet
cancer
recogn
case
epstein
barr
human
tlymphotrop
virusinduc
human
lymphoma
similar
virus
nonhuman
primat
miller
et
al
donahu
et
al
feichting
et
al
vereid
sugden
qayyum
choi
addit
proven
subgroup
j
avian
leukosi
viru
associ
develop
histiocyt
sarcomatosi
chicken
pandiri
et
al
associ
persist
epstein
barr
viru
infect
human
hs
report
kramer
et
al
studi
appli
sequenc
independ
viru
discoveri
techniqu
combin
high
throughput
sequenc
de
vri
et
al
investig
possibl
involv
previous
unknown
viru
develop
hs
n
coucang
sever
sequenc
homolog
parvovir
gene
identifi
indic
presenc
novel
parvoviru
whose
genom
subsequ
fulli
sequenc
parvovirus
viral
famili
parvovirida
small
nonenvelop
singl
strand
dna
virus
abl
infect
wide
rang
speci
vertebr
subfamili
parvovirina
arthropod
subfamili
densovirina
accord
latest
ictv
classif
genera
recogn
within
subfamili
parvovirina
includ
virus
infect
primat
cotmor
et
al
cotmor
tattersal
parvovirus
classifi
within
genu
dependoparvoviru
need
presenc
helper
viru
product
infect
virus
within
generath
call
autonom
parvovirusesar
phasedepend
cell
must
undergo
phase
growth
viral
replic
occur
bern
spectrum
parvoviru
induc
diseas
mainli
involv
young
individu
wide
vari
sever
form
like
sever
enter
high
mortal
young
dog
goddard
leisewitz
erythema
infectiosum
hydrop
fetali
children
caus
parvoviru
heegaard
brown
p
aleutian
diseas
mink
best
bloom
milder
form
like
common
respiratori
gastrointestin
diseas
human
jartti
et
al
final
parvoviru
infect
also
occur
asymptomat
individu
heegaard
brown
p
lau
et
al
clegg
et
al
although
formal
proof
exist
oncovirus
within
famili
parvovirus
report
literatur
associ
solid
hematopoiet
cancer
fisgin
et
al
li
et
al
schildgen
et
al
ibrahem
et
al
howev
sinc
reli
activ
replic
cell
increas
presenc
virus
individu
cancer
might
also
deriv
permiss
natur
tumor
cell
virus
even
proven
possess
oncosuppress
effect
transform
cell
bern
et
al
besid
report
discoveri
molecular
character
novel
parvoviru
scope
studi
determin
whether
possibl
correl
exist
viru
presenc
histiocyt
sarcoma
n
coucang
viru
identifi
year
old
male
nycticebu
coucang
slow
lori
name
buddha
held
captiv
year
duke
univers
primat
center
prior
signific
health
issu
individu
diagnos
neoplasia
euthan
due
poor
condit
although
routin
physic
inspect
month
death
reveal
enlarg
spleen
complet
postmortem
examin
perform
repres
tissu
buddha
collect
fix
neutral
formalin
fix
tissu
process
routin
paraffin
block
section
stain
hematoxylin
eosin
review
board
certifi
veterinari
pathologist
twenti
serum
sampl
belong
individu
n
coucang
nycticebu
pygmaeu
organ
collect
necropsi
belong
individu
n
coucanginclud
buddhaand
n
pygmaeu
screen
presenc
viru
organ
sampl
includ
liver
spleen
kidney
lung
heart
intestin
small
intestin
larg
intestin
altogeth
sampl
belong
individu
n
coucang
n
pygmaeu
variou
type
diseas
liver
spleen
kidney
lung
intestin
sampl
buddha
avail
well
serum
whole
blood
collect
differ
time
point
year
serum
year
serum
year
whole
blood
year
serum
serum
sampl
organ
store
c
virolog
examin
perform
hous
manag
sampl
collect
anim
report
approv
appropri
feder
institut
regulatori
author
sequenc
independ
viru
discoveri
perform
serum
sampl
collect
buddha
necropsi
previous
describ
procedur
minor
modif
centrifug
dnase
treatment
remov
intact
cell
host
dna
deriv
broken
cell
viral
nucleic
acid
isol
serum
qiamp
dna
mini
kit
qiagen
subsequ
ligat
adaptor
contain
specif
primer
bind
sequenc
amplicon
sizeselect
perform
prevent
amplif
dna
fragment
smaller
bp
use
agencourt
ampur
xp
bead
beckman
coulter
follow
cycl
pcr
amplif
amplifi
librari
subject
consecut
purif
round
agencourt
ampur
xp
bead
complet
remov
excess
primer
short
fragment
dna
concentr
measur
qubit
fluoromet
quantit
ds
dna
hs
kit
invitrogen
librari
pool
sampl
averag
size
whole
librari
estim
agil
high
sensit
dna
kit
agil
technolog
final
concentr
calcul
use
kapa
librari
quantif
kit
kapa
biosystem
sampl
dilut
final
concentr
million
use
input
emuls
pcr
liba
empcr
kit
roch
pyrosequenc
roch
sequenc
primer
sequenc
trim
everi
read
sequenc
assembl
codoncod
align
softwar
version
contig
consensu
sequenc
deriv
read
found
multipl
time
unassembl
sequenc
compar
known
nucleotid
protein
sequenc
genbank
databas
use
differ
standalon
blast
tool
blastn
tblastx
altschul
et
al
blast
result
visual
use
megan
softwar
version
huson
et
al
specif
primer
design
viral
sequenc
identifi
pcr
use
dreamtaq
dna
polymeras
thermo
scientif
perform
connect
fragment
sequenc
reaction
carri
nest
primer
directli
amplifi
product
use
big
dye
termin
chemistri
termin
cycl
sequenc
kit
appli
biosystem
end
genom
determin
use
genom
fragment
obtain
specif
digest
differ
restrict
enzym
msei
cviaii
new
england
biolab
obtain
overlap
fragment
vidisca
adaptor
subsequ
ligat
semi
specif
pcr
perform
combin
one
primer
anneal
known
viral
sequenc
one
adaptor
sequenc
obtain
amplicon
novel
sequenc
use
templat
new
primer
design
whole
procedur
repeat
reach
end
genom
specif
pcr
use
confirm
primer
use
pcr
sequenc
reaction
avail
upon
request
dna
isol
perform
serum
qiamp
dna
mini
kit
qiagen
blood
mg
tissu
mg
spleen
dneasi
blood
tissu
kit
qiagen
absolut
quantif
viral
dna
copiesml
serum
blood
copiesg
tissu
achiev
use
plasmidbas
standard
portion
orf
posit
complet
genom
nt
amplifi
clone
clone
vector
accord
instruct
manufactur
ta
clone
invitrogen
follow
plasmid
purif
plasmid
dna
purif
nucleobond
xtra
midi
machereynagel
quantif
nanodrop
thermo
scientif
quantit
real
time
pcr
assay
perform
iq
supermix
biorad
use
dna
input
follow
primer
probe
buddhartf
gctaatctggtgggaagaagg
buddhartr
cctttgcgatctaccctgac
buddhartp
famccgccaaggagagccttagcactamra
realtim
pcr
reaction
perform
light
cycler
system
roch
detect
possibl
differ
sequenc
obtain
variou
organ
differ
year
posit
sampl
subject
specif
amplif
nt
long
portion
gene
use
dreamtaq
dna
polymeras
thermo
scientif
primer
ccactcattctggtgand
gtagatgacttc
amplicon
dilut
directli
sequenc
employ
big
dye
termin
chemistri
termin
cycl
sequenc
kit
appli
biosystem
detect
presenc
latent
viral
form
extrachromosom
circular
episom
dna
integr
dna
differ
tissu
specif
pcrbase
assay
design
graphic
overview
method
use
detect
latenc
avail
figur
purpos
dna
isol
organ
collect
necropsi
buddha
lung
liver
spleen
kidney
small
larg
intestin
blood
collect
one
year
anim
die
use
input
detect
presenc
circular
viral
genom
invert
nest
pcr
perform
use
primer
anneal
end
two
open
read
frame
orf
figur
first
step
amplif
ttaatggctttgattcccagand
tcgagtaaaataccgacacatgfor
nest
amplif
control
dna
isol
serum
sampl
collect
without
vidisca
pretreat
also
includ
detect
chromosomeintegr
viral
form
differ
approach
employ
involv
specif
enzymat
digest
isol
dna
figur
dna
eluat
cut
restrict
site
nucleotid
reaction
mix
contain
u
ndei
restrict
enzym
new
england
biolab
incub
h
c
prior
inactiv
cut
dna
collect
use
perform
specif
ligat
vidisca
adaptor
digest
fragment
use
u
dna
ligas
life
technolog
afterward
semi
virusspecif
nest
amplif
perform
use
one
primer
complementari
viru
side
side
one
adaptor
specif
primer
parallel
cut
dna
subject
inactiv
step
min
c
follow
overnight
incub
room
temperatur
u
dna
ligas
allow
selflig
consequ
circular
digest
fragment
contain
host
sequenc
flank
viral
integr
dna
two
specif
invert
nest
pcr
use
afterward
primer
pair
tcccga
cacaaataatcggacaacc
gacgtgctttgttagaatctgttcctg
first
step
gaaatttgaatttccatc
ttagcttgagtc
caaacc
ctgcaatggtgtgtagatg
second
amplif
step
third
approach
integr
dna
detect
made
use
alu
element
dna
sequenc
highli
repeat
primat
genom
strub
primer
nyalu
cctcccagagtgctaggattgcac
bind
one
region
design
accord
genbank
sequenc
access
number
use
alon
neg
control
combin
viral
specif
primer
first
amplif
step
nest
amplif
amplifi
put
integr
region
figur
amplif
perform
use
dna
input
pcr
mix
contain
dreamtaq
dna
polymeras
thermo
scientif
primer
pcr
perform
accord
follow
thermo
profil
initi
denatur
c
min
follow
cycl
nest
pcr
c
c
c
min
episom
dna
test
min
integr
test
final
elong
cycl
c
min
posit
pcr
product
clone
clone
vector
ta
clone
invitrogen
sequenc
employ
big
dye
termin
chemistri
termin
cycl
sequenc
kit
appli
biosystem
use
betain
final
concentr
resolv
secondari
structur
dna
character
phylogenet
placement
novel
viru
amino
acid
sequenc
known
parvovirus
download
genbank
databas
align
togeth
one
predict
studi
obtain
nucleotid
sequenc
use
cobalt
multipl
align
tool
http
wwwncbinlm
nihgovtoolscobalt
complet
sequenc
includ
analysi
align
manual
edit
need
bioedit
softwar
version
hall
use
phylogenet
infer
model
select
perform
identifi
best
model
distanc
estim
phylogenet
tree
construct
mega
softwar
version
tamura
et
al
use
maximumlikelihood
method
felsenstein
test
robust
analysi
bootstrap
analysi
replic
felsenstein
perform
cluster
associ
valu
higher
consid
signific
identifi
possibl
mutat
viral
sequenc
amplifi
differ
tissu
differ
time
point
nucleotid
sequenc
align
use
clustalx
version
larkin
et
al
ident
sequenc
calcul
bioedit
softwar
version
hall
dna
secondari
structur
predict
obtain
use
mfold
web
server
http
mfoldrnaalbanyedu
qmfold
downloadmfold
genom
sequenc
obtain
studi
deposit
genbank
databas
access
number
examin
case
buddha
male
slow
lori
euthan
age
year
diffus
hs
serum
sampl
collect
necropsi
use
input
viru
discoveri
search
novel
viru
could
explain
diseas
postmortem
examin
princip
observ
includ
significantli
enlarg
spleen
homogen
frontier
microbiolog
virolog
decemb
volum
articl
cut
surfac
mottl
liver
irregular
patch
pallor
pancreat
mediastin
lymph
node
enlarg
incident
lesion
includ
cystic
mass
right
mammari
gland
sever
small
ulcer
fundu
stomach
histolog
examin
spleen
reveal
loss
normal
architectur
intens
infiltr
neoplast
round
polygon
cell
moder
variat
cell
nuclear
size
anisocytosi
anisokaryosi
mitot
figur
common
multinucl
cell
occasion
seen
liver
similar
neoplast
cell
aggreg
surround
portal
vein
central
vein
expand
associ
connect
tissu
ingest
red
blood
cell
erythrophagocytosi
neoplast
cell
also
observ
affect
lymph
node
character
loss
normal
architectur
replac
sheet
round
polygon
neoplast
cell
similar
found
liver
spleen
find
led
diagnosi
dissemin
histiocyt
sarcoma
addit
find
includ
evid
apocrin
gland
cyst
caus
mass
right
mammari
gland
addit
evid
inflamm
necrosi
adren
gland
associ
protozo
infect
interpret
toxoplasma
gondii
addit
larg
deepli
basophil
intranuclear
inclus
found
minor
adren
cortic
cell
renal
tubul
contain
eosinophil
droplet
epitheli
cell
often
seen
mice
histiocyt
sarcoma
although
caus
known
chronic
interstiti
nephriti
also
evid
explor
possibl
viral
involv
etiopathogenesi
hs
use
sequenc
independ
viru
identif
techniqu
abl
detect
virtual
dna
rna
viru
variou
clinic
sampl
van
der
hoek
et
al
canuti
et
al
jazaeri
farsani
et
al
tan
et
al
canuti
et
al
oud
munnink
et
al
pariani
et
al
total
sequenc
read
obtain
serum
sampl
slow
lori
hs
among
sequenc
identifi
homolog
differ
member
parvovirina
subfamili
identifi
blastn
nucleotid
ident
recogniz
ident
search
perform
amino
acid
level
amino
acid
ident
recogn
viral
fragment
use
templat
primer
design
combin
specif
pcr
genom
walk
techniqu
allow
retriev
almost
complet
genom
sequenc
viru
part
termin
repeat
lack
tent
name
slow
lori
parvoviru
genom
sequenc
allow
us
identifi
viral
sequenc
identifi
via
ident
search
total
read
total
belong
novel
viru
rule
set
parvoviru
studi
group
latest
ictv
report
mention
novel
parvoviru
lack
isol
classifi
within
parvovirida
famili
complet
code
sequenc
provid
typic
parvovir
motif
pattern
recogn
cotmor
et
al
genom
novel
parvoviru
nt
genom
organ
reflect
member
parvovirina
subfamili
larg
orf
termin
sequenc
form
end
loop
structur
import
viral
replic
although
structur
loop
could
entir
resolv
sinc
partial
sequenc
could
retriev
figur
bern
first
orfloc
part
genom
nt
put
encod
nonstructur
protein
aa
second
orfloc
part
nt
encod
capsid
protein
aa
molecular
featur
typic
parvovirus
also
identifi
figur
phospholipas
domain
conserv
major
parvovirus
essenti
viral
genom
transfer
nucleu
locat
ntermin
part
uniqu
region
contain
typic
pla
catalyt
domain
hdxxi
aa
ca
bind
loop
yxgxg
aa
et
al
anoth
molecular
marker
parvovirus
presenc
conserv
helicas
sequenc
motif
protein
walker
et
al
lou
et
al
within
carboxytermin
half
protein
aa
typic
atp
bind
loop
ploop
walker
box
gxxxxgk
ts
could
identifi
immedi
follow
mg
bind
walker
b
hhhh
de
e
b
motif
final
c
motif
stretch
hydrophob
residu
usual
follow
asparagin
common
helicas
belong
superfamili
type
iii
also
present
figur
abl
obtain
part
sequenc
termin
non
code
region
nt
end
respect
align
sequenc
show
ident
orient
opposit
direct
start
differenti
atg
start
codon
becom
acg
side
termin
sequenc
figur
data
suggest
possess
ident
invert
termin
repeat
besid
nt
sequenc
identifi
present
side
genom
taa
stop
codon
contain
nt
region
fold
small
hairpin
figur
phylogenet
analysi
perform
use
predict
amino
acid
sequenc
protein
belong
member
parvovirina
subfamili
figur
phylogenet
tree
parvovirina
genera
indic
defin
cluster
support
signific
bootstrap
valu
virus
cluster
clade
parvoviru
identifi
artibeu
jamaicensi
fruit
bat
previous
report
first
member
novel
parvoviru
genu
canuti
et
al
virus
locat
dependoparvoviru
tetraparvoviru
genera
significantli
cluster
known
parvoviru
possibl
repres
independ
still
undefin
genera
better
clarifi
relationship
close
relat
parvovirus
amino
acid
ident
enzymat
core
motif
indic
box
et
al
final
hypothet
specif
termin
hairpin
repres
dash
line
right
small
hairpin
identifi
end
genom
shown
underlin
stop
codon
mfold
web
server
http
mfold
rnaalbanyedu
qmfolddownloadmfold
use
predict
secondari
structur
protein
within
clade
calcul
tabl
consid
protein
viru
highest
ident
bovin
adenoassoci
viru
baav
follow
member
dependoparvoviru
genu
averag
clade
closest
tetraparvoviru
clade
approxim
equidist
trend
could
note
classif
rule
parvovirus
state
genu
defin
monophylet
group
amino
acid
sequenc
includ
virus
gener
ident
less
ident
genera
cotmor
et
al
accord
analysi
could
consid
first
member
novel
genera
amino
acid
sequenc
less
ident
one
virus
closest
genera
tabl
less
respect
part
bootstrap
support
monophylet
group
figur
twenti
serum
organ
sampl
altogeth
belong
individu
n
coucang
n
pygmaeu
screen
presenc
sampl
collect
anim
viru
origin
identifi
posit
organ
collect
necropsi
posit
decemb
volum
articl
figur
align
avail
invert
termin
repeat
sequenc
slow
lori
parvoviru
side
itr
orient
side
itr
orient
opposit
direct
start
codon
well
stop
codon
highlight
gray
sequenc
small
hairpin
uniqu
side
noncod
region
underlin
boldfac
viru
high
viral
load
shown
tabl
liver
spleen
kidney
organ
viru
reach
highest
load
surprisingli
bloodserum
sampl
collect
differ
time
point
pcr
posit
sampl
collect
buddha
time
frame
year
year
viru
constantli
found
moder
high
concentr
highest
titr
found
whole
blood
dna
copiesml
month
prior
death
anim
tabl
nt
fragment
orf
end
sequenc
posit
sampl
order
detect
variat
differ
bodi
site
among
year
infect
polymorph
site
note
tabl
polymorph
predominantli
includ
transit
two
nonsynonym
consid
sequenc
obtain
serum
accumul
substitut
transit
locat
codon
year
one
lead
amino
acid
chang
howev
fixat
account
consid
altogeth
sequenc
retriev
serum
organ
appear
new
variabl
site
time
also
note
like
codon
posit
polymorph
appear
interest
notic
kidney
intestin
locat
polymorph
site
character
earlier
time
point
conserv
posit
sinc
viru
detect
sampl
collect
buddha
year
presenc
integr
episom
viral
genom
could
postul
besid
disrupt
oncolyt
gene
caus
viral
integr
could
origin
hs
therefor
presenc
integr
viral
genom
tissu
includ
whole
blood
investig
mean
three
differ
method
sinc
integr
locat
could
predict
figur
evid
integr
virus
could
found
addit
also
evid
circular
coval
close
genom
form
could
persist
tissu
episom
form
cancer
one
lead
caus
human
death
worldwid
repres
consider
health
concern
domest
wild
anim
well
anim
kept
captiv
whocanc
misdorp
kelsey
et
al
mcaloos
newton
remick
et
al
although
full
process
tumorigenesi
complet
understood
known
accumul
mutat
protooncogen
involv
regul
suppress
cell
replic
tumor
effect
viral
infect
involv
progress
berger
benjamin
mcaloos
newton
number
recogn
oncogen
virus
increas
nowaday
sever
examplesboth
human
anim
fieldsar
well
character
best
known
exampl
papillomavirus
caus
cervic
cancer
human
differ
type
genit
cutan
cancer
aquat
mammal
hepadnavirus
caus
hepatocellular
carcinoma
human
woodchuck
epstein
barr
viru
respons
burkitt
lymphoma
retrovirus
origin
differ
type
malign
human
mammal
mcaloos
newton
braoudaki
tzortzatoustathopoul
butt
miggin
pannon
et
al
therefor
import
identifi
novel
oncovirus
extens
studi
order
understand
tumorigen
mechan
especi
light
futur
develop
prevent
strategi
studi
investig
case
diffus
histiocyt
sarcomaa
rare
aggress
type
hematopoiet
tumor
develop
differ
anim
speci
fulmer
mauldin
friedrich
young
soshin
et
al
molenaar
et
al
remick
et
al
takahashi
nakamura
investig
possibl
viral
involv
etiopathogenesi
hs
broad
spectrum
viru
discoveri
techniqu
employ
abl
detect
virtual
dna
rna
virus
present
clinic
sampl
oud
munnink
et
al
novel
parvoviru
identifi
molecularli
fulli
character
viru
name
slow
lori
parvoviru
around
kb
evolutionari
histori
member
parvovirina
subfamili
infer
use
maximum
likelihood
method
felsenstein
base
rtrev
freq
model
dimmic
et
al
identifi
best
fit
model
model
test
analysi
use
tamura
et
al
distanc
gamma
distribut
use
model
evolutionari
rate
differ
among
site
g
paramet
rate
variat
model
allow
site
evolutionarili
invari
site
posit
less
site
coverag
elimin
outcom
bootstrap
analysi
felsenstein
shown
next
branch
genera
design
squar
bracket
access
number
refer
strain
indic
next
strain
name
viru
describ
studi
indic
bold
decemb
volum
articl
vidisca
pretreat
centrifug
dnase
treatment
prior
dna
isol
size
possess
molecular
featur
typic
parvovirus
includ
sequenc
code
conserv
enzymat
motif
main
orf
flank
noncod
termin
region
appear
ident
invert
like
describ
parvovirus
lusbi
et
al
bern
deiss
et
al
viru
phylogenet
locat
dependoparvoviru
tetraparvoviru
genera
accord
classif
rule
defin
ictv
cotmor
et
al
possibl
first
member
new
genu
thank
avail
seri
serum
organ
sampl
collect
multipl
year
slow
lori
variou
diseas
abl
screen
differ
sampl
total
individu
belong
n
coucang
speci
closest
relat
speci
n
pygmaeu
anim
posit
viru
expect
organ
collect
necropsi
posit
also
report
parvovirus
meunier
et
al
canuti
et
al
liver
spleen
kidney
organ
viru
reach
highest
load
high
viral
concentr
found
organ
might
reflect
elev
content
blood
blood
cell
besid
histolog
investig
presenc
basophil
inclus
renal
tissu
could
observ
might
repres
parvovir
accumul
similar
report
parvovirus
vivo
hay
et
al
bestetti
zwahlen
porter
et
al
decaro
buonavoglia
vitro
inaba
et
al
oleksiewicz
et
al
surprisingli
blood
serum
sampl
collect
variou
year
posit
rather
constant
load
could
detect
viremia
year
prior
death
anim
given
involv
diseas
white
blood
cell
presum
condit
immunosuppress
caus
either
viru
tumor
combin
factor
postul
might
possibl
explan
fact
viru
clear
year
suppos
presenc
immunodefici
lori
support
detect
opportunist
infect
patholog
test
report
presenc
toxoplasma
gondii
infect
sinc
hs
fast
aggress
type
cancer
could
hypothes
viru
present
lori
tumor
develop
histiocyt
refer
cell
either
macrophag
dendrit
cell
lineag
aris
common
precursor
cell
neoplasm
histiocyt
aris
macrophag
one
two
type
dendrit
cell
langerhan
cell
interstiti
dendrit
cell
langerhan
cell
found
within
epithelium
interstiti
dendrit
cell
occupi
perivascular
posit
tissu
form
hs
anim
aris
malign
prolifer
interstiti
dendrit
cell
although
one
form
hemophagocyt
variant
aris
macrophag
fulmer
mauldin
takahashi
nakamura
moor
establish
classif
scheme
hs
prosimian
interpret
tumor
like
arisen
interstiti
dendrit
cell
parvovirus
proven
tropism
cell
hematopoiet
system
bone
marrow
provid
perfect
condit
parvovir
replic
sinc
wide
spectrum
cell
differ
divid
stage
present
parvovirus
need
activ
divid
cell
phase
replic
bern
segovia
et
al
fact
hematopoiet
wwwfrontiersinorg
decemb
volum
articl
disord
like
leucopenia
alter
bone
marrow
observ
infect
individu
larsen
et
al
boosing
et
al
although
formal
proof
exist
oncoparvovirus
caus
link
novel
parvoviru
hs
could
rule
therefor
investig
hypothesi
explor
eventu
presenc
latent
form
viru
known
parvovirus
establish
latenc
integr
host
genom
schnepp
et
al
kapoor
et
al
integr
event
might
caus
disrupt
import
oncosuppressor
one
initi
caus
tumor
develop
episom
dna
form
variou
parvovirus
recent
detect
kapoor
et
al
zhao
et
al
parvovir
dna
found
persist
differ
tissu
schneider
et
al
norja
et
al
sometim
even
correl
tumor
li
et
al
schildgen
et
al
although
without
caus
link
sinc
imposs
predict
way
viru
would
persist
hypothesi
test
differ
method
aim
identifi
either
potenti
integr
viral
dna
circular
coval
close
genom
persist
tissu
episom
form
none
approach
gave
evid
latent
form
viru
test
organ
includ
whole
blood
mutat
hotspot
locat
end
side
orf
identifi
increas
variat
year
observ
evolutionari
rate
estim
literatur
parvovirus
around
substitut
per
site
per
year
studi
genom
region
shackelton
holm
zehend
et
al
streck
et
al
amount
substitut
observ
reflect
rate
howev
previous
publish
rate
estim
anim
popul
level
interhost
addit
fixat
rate
connect
transmiss
rout
viru
sequenc
viral
subpopul
transmit
individu
depend
viral
variat
bodi
site
viru
shed
sinc
infect
individu
identifi
postul
could
made
transmiss
rout
viru
also
evolutionari
rate
estim
possibl
nevertheless
observ
increas
sequenc
variat
time
inconsist
latenc
hypothesi
integr
viru
would
evolv
evolutionari
rate
host
therefor
case
integr
variat
would
observ
reason
believ
caus
malign
mere
found
ideal
replic
condit
cancer
cell
sinc
discuss
well
known
parvovirus
need
activ
replic
cell
sphase
order
prolifer
bern
fact
known
certain
virus
call
oncolyt
virus
tropism
specif
cancer
cell
even
lead
spontan
regress
malign
butt
miggin
sze
et
al
proven
adenoassoci
dependoparvoviru
although
indirect
way
enhanc
adenovir
replic
rodent
parvoviru
et
al
laborda
et
al
futur
research
clarifi
whether
viral
infect
preced
tumor
develop
role
oncogen
process
whether
viru
simpli
benefit
replic
activ
cancer
cell
persist
viremia
correl
hs
answer
question
obtain
identifi
cell
type
viral
replic
occur
detect
infect
lori
constant
monitor
physic
condit
diseas
progress
discoveri
relat
virus
anim
similar
malign
although
studi
requir
provid
conclus
answer
infect
might
delay
tumor
progress
mechan
proven
feasibl
new
excit
possibl
might
open
oncolyt
parvovirotherapi
et
al
russel
et
al
conclus
discov
molecularli
character
novel
parvoviru
first
member
yet
defin
genu
first
describ
prosimian
viru
identifi
slow
lori
hs
found
evid
caus
involv
neoplast
diseas
postul
viru
replic
advantag
deriv
constantli
replic
cancer
cell
